Advantest Corp
TSE:6857
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 615
9 824
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Advantest Corp
Current Assets | 519.6B |
Cash & Short-Term Investments | 167.2B |
Receivables | 114.1B |
Other Current Assets | 238.4B |
Non-Current Assets | 242.5B |
Long-Term Investments | 18.3B |
PP&E | 92.1B |
Intangibles | 96.2B |
Other Non-Current Assets | 36B |
Current Liabilities | 174.3B |
Accounts Payable | 96B |
Other Current Liabilities | 78.3B |
Non-Current Liabilities | 112B |
Long-Term Debt | 86.6B |
Other Non-Current Liabilities | 25.3B |
Balance Sheet
Advantest Corp
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
97 574
|
85 430
|
95 324
|
103 973
|
119 943
|
127 703
|
149 164
|
116 582
|
85 537
|
106 702
|
|
Cash Equivalents |
97 574
|
85 430
|
95 324
|
103 973
|
119 943
|
127 703
|
149 164
|
116 582
|
85 537
|
106 702
|
|
Total Receivables |
26 478
|
28 005
|
32 451
|
37 929
|
51 786
|
46 426
|
57 028
|
82 155
|
102 152
|
88 855
|
|
Accounts Receivables |
25 400
|
27 729
|
30 983
|
34 212
|
49 856
|
44 100
|
54 131
|
72 379
|
89 795
|
74 153
|
|
Other Receivables |
1 078
|
276
|
1 468
|
3 717
|
1 930
|
2 326
|
2 897
|
9 776
|
12 357
|
14 702
|
|
Inventory |
38 159
|
33 912
|
39 093
|
49 627
|
57 099
|
58 943
|
64 340
|
95 013
|
169 082
|
204 389
|
|
Other Current Assets |
2 430
|
3 049
|
4 271
|
5 614
|
4 423
|
7 070
|
8 563
|
11 195
|
17 924
|
20 315
|
|
Total Current Assets |
164 641
|
150 396
|
171 139
|
197 143
|
233 251
|
240 142
|
279 095
|
304 945
|
374 695
|
420 261
|
|
PP&E Net |
34 216
|
31 451
|
29 915
|
29 232
|
30 786
|
46 256
|
53 281
|
64 037
|
81 358
|
97 990
|
|
PP&E Gross |
34 216
|
31 451
|
29 915
|
29 232
|
30 786
|
46 256
|
53 281
|
64 037
|
81 358
|
97 990
|
|
Accumulated Depreciation |
67 649
|
64 313
|
64 626
|
57 951
|
59 079
|
67 098
|
70 299
|
77 931
|
89 264
|
108 968
|
|
Intangible Assets |
2 187
|
1 735
|
1 553
|
1 153
|
1 272
|
4 106
|
21 765
|
22 120
|
32 675
|
33 260
|
|
Goodwill |
15 988
|
14 991
|
14 926
|
14 134
|
24 847
|
46 919
|
32 778
|
63 187
|
63 092
|
65 254
|
|
Long-Term Investments |
5 248
|
4 025
|
3 837
|
2 816
|
3 218
|
3 003
|
10 211
|
14 565
|
21 488
|
20 139
|
|
Other Long-Term Assets |
10 957
|
7 853
|
10 233
|
10 081
|
11 206
|
15 351
|
25 511
|
25 842
|
26 916
|
34 325
|
|
Other Assets |
15 988
|
14 991
|
14 926
|
14 134
|
24 847
|
46 919
|
32 778
|
63 187
|
63 092
|
65 254
|
|
Total Assets |
233 237
N/A
|
210 451
-10%
|
231 603
+10%
|
254 559
+10%
|
304 580
+20%
|
355 777
+17%
|
422 641
+19%
|
494 696
+17%
|
600 224
+21%
|
671 229
+12%
|
|
Liabilities | |||||||||||
Accounts Payable |
19 550
|
13 305
|
19 166
|
31 378
|
28 551
|
31 434
|
40 304
|
49 566
|
66 185
|
128 423
|
|
Accrued Liabilities |
10 121
|
8 796
|
9 323
|
11 880
|
15 391
|
15 226
|
18 254
|
20 786
|
23 077
|
25 303
|
|
Short-Term Debt |
10 000
|
0
|
0
|
0
|
0
|
0
|
0
|
18 359
|
0
|
0
|
|
Current Portion of Long-Term Debt |
271
|
487
|
15 000
|
29 872
|
0
|
2 275
|
2 486
|
2 918
|
17 944
|
5 147
|
|
Other Current Liabilities |
9 396
|
6 846
|
7 945
|
14 067
|
18 906
|
21 602
|
28 767
|
59 253
|
67 483
|
44 267
|
|
Total Current Liabilities |
49 338
|
29 434
|
51 434
|
87 197
|
62 848
|
70 537
|
89 811
|
150 882
|
174 689
|
126 277
|
|
Long-Term Debt |
44 492
|
44 618
|
29 745
|
0
|
0
|
9 013
|
9 364
|
22 186
|
32 900
|
89 296
|
|
Deferred Income Tax |
389
|
358
|
420
|
1 099
|
1 680
|
1 563
|
4 473
|
3 445
|
5 773
|
3 934
|
|
Other Liabilities |
37 208
|
42 422
|
40 487
|
41 653
|
41 321
|
43 212
|
38 624
|
23 562
|
18 168
|
20 544
|
|
Total Liabilities |
131 427
N/A
|
116 832
-11%
|
122 086
+4%
|
129 949
+6%
|
105 849
-19%
|
124 325
+17%
|
142 272
+14%
|
200 075
+41%
|
231 530
+16%
|
240 051
+4%
|
|
Equity | |||||||||||
Common Stock |
32 363
|
32 363
|
32 363
|
32 363
|
32 363
|
32 363
|
32 363
|
32 363
|
32 363
|
32 363
|
|
Retained Earnings |
106 916
|
105 190
|
113 676
|
125 204
|
125 927
|
159 803
|
214 858
|
279 828
|
319 171
|
355 299
|
|
Additional Paid In Capital |
44 487
|
44 478
|
44 319
|
43 466
|
43 018
|
43 550
|
44 573
|
44 995
|
44 622
|
45 441
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Treasury Stock |
94 686
|
94 585
|
86 039
|
77 724
|
6 262
|
4 179
|
15 001
|
81 547
|
59 099
|
56 353
|
|
Other Equity |
12 730
|
6 173
|
5 198
|
1 301
|
3 685
|
85
|
3 576
|
18 982
|
31 637
|
54 428
|
|
Total Equity |
101 810
N/A
|
93 619
-8%
|
109 517
+17%
|
124 610
+14%
|
198 731
+59%
|
231 452
+16%
|
280 369
+21%
|
294 621
+5%
|
368 694
+25%
|
431 178
+17%
|
|
Total Liabilities & Equity |
233 237
N/A
|
210 451
-10%
|
231 603
+10%
|
254 559
+10%
|
304 580
+20%
|
355 777
+17%
|
422 641
+19%
|
494 696
+17%
|
600 224
+21%
|
671 229
+12%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
175
|
175
|
177
|
179
|
198
|
198
|
786
|
760
|
737
|
738
|